CH1: COST-EFFECTIVENESS ANALYSIS OF IRINOTECAN AS FIRST-LINE THERAPY IN ADVANCED COLORECTAL CANCER
C Schmitt, C Levy-Piedbois, M Frappe, I Durand-ZaleskiVolume:
3
Year:
2000
Language:
english
DOI:
10.1016/s1098-3015(11)70645-3
File:
PDF, 54 KB
english, 2000